Inovio’s Ebola vaccine has positive results in early human trials

Inovio said Wednesday its Ebola vaccine was safe and effective in early-stage human trials.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.